Safety and Immunogenicity of High Dose Trivalent Inactivated Influenza Vaccine in Pediatric Patients with Acute Lymphoblastic Leukemia

被引：0
|
作者：
McManus, Meghann Pine [1 ]
Frangoul, Haydar [2 ]
McCullers, Jonathan [3 ]
Wang, Wenli [2 ]
Ampath, Steve [2 ]
O'Shea, Alice [2 ]
Halasa, Natasha [2 ]
机构：
[1] Univ Utah, Primary Childrens Med Ctr, Salt Lake City, UT USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[3] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.3531.3531
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3531
引用
收藏
页数：2
相关论文
共 50 条
  • [21] High-dose trivalent inactivated influenza vaccine safe in elderly
    Reactions Weekly, 2020, 1816 (1) : 7 - 7
  • [22] Immunogenicity and Safety of an Inactivated Trivalent Split Influenza Virus Vaccine in Young Children with Recurrent Wheezing
    Bae, E. Young
    Choi, Ui Yoon
    Kwon, Hyo Jin
    Jeong, Dae Chul
    Rhim, Jung Woo
    Ma, Sang Hyuk
    Lee, Kyung Il
    Kang, Jin Han
    CLINICAL AND VACCINE IMMUNOLOGY, 2013, 20 (06) : 811 - 817
  • [23] Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults
    Beran, Jiri
    Peeters, Mathieu
    Dewe, Walthere
    Raupachova, Jolana
    Hobzova, Lenka
    Devaster, Jeanne-Marie
    BMC INFECTIOUS DISEASES, 2013, 13
  • [24] Trivalent inactivated subunit influenza vaccine Influvac®: 25-Year experience of safety and immunogenicity
    Giezeman, K. M.
    Nauta, J.
    de Bruijn, I. A.
    Palache, A. M.
    VACCINE, 2009, 27 (18) : 2414 - 2417
  • [25] Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults
    Jiří Beran
    Mathieu Peeters
    Walthère Dewé
    Jolana Raupachová
    Lenka Hobzová
    Jeanne-Marie Devaster
    BMC Infectious Diseases, 13
  • [26] Comparison of Side Effects of the 2015-2016 High-Dose, Inactivated, Trivalent Influenza Vaccine and Standard Dose, Inactivated, Trivalent Influenza Vaccine in Adults ≥ 65 Years
    Kaka, Anjum S.
    Filice, Gregory A.
    Myllenbeck, Sharon
    Nichol, Kristin L.
    OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (01):
  • [27] Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults
    Pepin, Stephanie
    Donazzolo, Yves
    Jambrecina, Alen
    Salamand, Camille
    Saville, Melanie
    VACCINE, 2013, 31 (47) : 5572 - 5578
  • [28] Influenza vaccination in adults with asthma: Safety of an inactivated trivalent influenza vaccine
    Kmiecik, T.
    Arnoux, Sabine
    Kobryn, Aleksandra
    Gorski, Pawel
    JOURNAL OF ASTHMA, 2007, 44 (10) : 817 - 822
  • [29] Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects
    Couch, Robert B.
    Winokur, Patricia
    Brady, Rebecca
    Belshe, Robert
    Chen, Wilbur H.
    Cate, Thomas R.
    Sigurdardottir, Bryndis
    Hoeper, Amy
    Graham, Irene L.
    Edelman, Robert
    He, Fenhua
    Nino, Diane
    Capellan, Jose
    Ruben, Frederick L.
    VACCINE, 2007, 25 (44) : 7656 - 7663
  • [30] Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China versus a comparator influenza vaccine: a phase IV randomized study
    Hu, Yuemei
    Chu, Kai
    Lavis, Nathalie
    Li, Xiaoling
    Liang, Bill
    Liu, Shuzhen
    Shao, Ming
    Shu, Jean-Denis
    Tabar, Cynthia
    Samson, Sandrine
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (05) : 1066 - 1069
12345